Title:
抗ウイルス用組成物、抗ノロウイルス用組成物、スプレー、ワイパー、化合物
Document Type and Number:
Japanese Patent JP7132332
Kind Code:
B2
Abstract:
The present invention addresses the problem of providing an antiviral composition that shows a high solubility of an antiviral component and has an excellent antiviral activity. The present invention further addresses the problem of providing an anti-norovirus composition comprising the antiviral composition. The present invention furthermore addresses the problem of providing a spray and a wiper using the antiviral composition, and, moreover, a novel compound. The antiviral composition according to the present invention comprises a compound, which has a phenolic hydroxyl group, one or more kinds of acidic groups selected from the group consisting of a carboxy group, a sulfo group, a sulfinate group, a phosphate group, a phosphinate group, a phosphonate group and a group represented by general formula (a), and an aliphatic hydrocarbon group having 6 or more carbon atoms, and an alcohol-containing solvent and has a pH value of 9.0-14.0. General formula (a): *-SO2NHSO2Rx1. In general formula (a), Rx1 represents a monovalent aliphatic hydrocarbon group, an aryl group or a heteroaryl group, and * represents a binding position.
Inventors:
Hiroki Sugiura
Naotoshi Sato
Naotoshi Sato
Application Number:
JP2020532472A
Publication Date:
September 06, 2022
Filing Date:
July 25, 2019
Export Citation:
Assignee:
FUJIFILM Corporation
International Classes:
C07C65/21; A01N25/02; A01N25/04; A01N37/10; A01N37/18; A01P1/00; C07C65/28; C07C69/84; C07C235/46
Domestic Patent References:
| JP2002205139A | ||||
| JP2009179577A | ||||
| JP2010505964A | ||||
| JP57192342A |
Foreign References:
| WO1994021591A1 | ||||
| KR1020100012928A |
Other References:
REGISTRY(STN)[online],2004年,[検索日 2022.03.17] CAS登録番号790652-64-1, 748763-29-3
Toxicology in Vitro,2008年,22(6),P.1534-1538
Journal of Organic Chemistry,2007年,72(22),P.8167-8174,Supporting Information S1-S46
Journal of the American Chemical Society,2005年,127(6),P.1737-1743,Supporting Information S1-S43
Macromolecular Chemistry and Physics,2000年,201(14),P.1753-1757
Macromolecules,1998年,31(24),P.8595-8599
Journal of Pharmaceutical Sciences,1977年,66(4),P.546-549
Medical Science Monitor,18(8),2012年,P.BR293-298
Journal of Medicinal Chemistry,35(26),1992年,P.4846-4853
Journal of Medicinal Chemistry,1991年,34(1),P.212-217
Heterocycles,2005年,65(10),P.2431-2439
International Journal of Pharmaceutical Sciences Review and Research,2015年,31(2),P.210-217
REGISTRY(STN)[online],2010.10.11[検索日 2019.10.02] CAS登録番号1245946-03-5
Synthesis,2005年,(6),P.1019-1027
Journal of Faculty of Pharmacy of Gazi University,2000年,17(1),P.1-6
Toxicology in Vitro,2008年,22(6),P.1534-1538
Journal of Organic Chemistry,2007年,72(22),P.8167-8174,Supporting Information S1-S46
Journal of the American Chemical Society,2005年,127(6),P.1737-1743,Supporting Information S1-S43
Macromolecular Chemistry and Physics,2000年,201(14),P.1753-1757
Macromolecules,1998年,31(24),P.8595-8599
Journal of Pharmaceutical Sciences,1977年,66(4),P.546-549
Medical Science Monitor,18(8),2012年,P.BR293-298
Journal of Medicinal Chemistry,35(26),1992年,P.4846-4853
Journal of Medicinal Chemistry,1991年,34(1),P.212-217
Heterocycles,2005年,65(10),P.2431-2439
International Journal of Pharmaceutical Sciences Review and Research,2015年,31(2),P.210-217
REGISTRY(STN)[online],2010.10.11[検索日 2019.10.02] CAS登録番号1245946-03-5
Synthesis,2005年,(6),P.1019-1027
Journal of Faculty of Pharmacy of Gazi University,2000年,17(1),P.1-6
Attorney, Agent or Firm:
Hideaki Ito
Fumio Mihashi
Fumio Mihashi